Timothy J. Hahn, PhD

Dr. Hahn is senior vice president of CMC for NanoFlu with responsibility for leading all CMC activities for the NanoFlu program. Dr. Hahn has 28 years of commercial vaccine and antibody manufacturing experience and a proven track record with clinical and commercial products, process innovation, technology transfer, facility start-up, GMP compliance, and regulatory inspections. Dr. Hahn joined Novavax in June 2011 as senior vice president of manufacturing and process development and was later named senior vice president of global manufacturing operations with responsibility for production sites in the United States and Europe. Prior to joining Novavax, he was vice president of antibody manufacturing and later vice president of vaccine manufacturing at MedImmune, LLC, with responsibilities for sites in the United States and Europe. Prior to MedImmune, he spent more than 15 years in vaccine manufacturing with Merck & Co. Dr. Hahn received a bachelor of science degree in chemical engineering from Lehigh University and a master of science and a doctorate degree in chemical engineering from Stanford University.